A detailed history of Icon Wealth Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Icon Wealth Advisors, LLC holds 38,146 shares of ABBV stock, worth $7.23 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares
38,146
Previous 35,608 7.13%
Holding current value
$7.23 Million
Previous $6.48 Million 0.89%
% of portfolio
0.56%
Previous 0.61%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $392,857 - $458,768
2,538 Added 7.13%
38,146 $6.54 Million
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $18,858 - $21,487
-118 Reduced 0.33%
35,608 $6.48 Million
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $2.51 Million - $2.82 Million
-18,227 Reduced 33.78%
35,726 $5.54 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $246,191 - $295,248
1,780 Added 3.41%
53,953 $8.72 Million
Q3 2022

Jan 25, 2023

BUY
$134.21 - $153.93 $7 Million - $8.03 Million
52,173 New
52,173 $7 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $335B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Icon Wealth Advisors, LLC Portfolio

Follow Icon Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Icon Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Icon Wealth Advisors, LLC with notifications on news.